Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

ClinicalTrials.gov ID: NCT01539512

Public ClinicalTrials.gov record NCT01539512. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 2:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia

Study identification

NCT ID
NCT01539512
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
220 participants

Conditions and interventions

Interventions

  • Idelalisib Drug
  • Placebo to match idelalisib Drug
  • Rituximab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2012
Primary completion
Sep 30, 2013
Completion
Mar 31, 2014
Last update posted
May 13, 2019

2012 – 2014

United States locations

U.S. sites
34
U.S. states
17
U.S. cities
30
Facility City State ZIP Site status
Clearview Cancer Institute Huntsville Alabama 35805
Arizona Oncology Associates Tucson Arizona 85704
University of California, San Diego- Moores Cancer Center La Jolla California 92093
Ventura County Hematology Oncology Specialists Oxnard California 93030
UCLA Santa Monica California 90404
Stanford Cancer Center Stanford California 94305
Rocky Mountain Blood and Marrow Transplant Program Denver Colorado 80218
Rocky Mountain Cancer Center Denver Colorado 80218
Georgetown University Medical Center Lombardi Cancer Center Washington D.C. District of Columbia 20057
Collaborative Medical Research Corporation Boynton Beach Florida 33435
Collaborative Research Group LLC Boynton Beach Florida 33435
Florida Cancer Specialists Fort Myers Florida 33916
University of Florida Gainesville Florida 32610
Florida Cancer Specialists St. Petersburg Florida 33705
Winship Cancer Institute at Emory University Atlanta Georgia 30322
Northwestern University Chicago Illinois 60611
Hackensack University Medical Center Hackensack New Jersey 07601
Hematology Oncology Associates of Northern New Jersey Morristown New Jersey 07962
Long Island Jewish Medical Center New Hyde Park New York 11042
Weill Cornell Medical College New York New York 10021
Columbia University Medical Center New York New York 10032
Memorial Sloan Kettering Cancer Center New York New York 10065
Willamette Valley Cancer Center Springfield Oregon 97477
Northwest Cancer Specialists, PC Tualatin Oregon 97062
Cancer Centers of the Carolinas Greenville South Carolina 29605
Sarah Cannon Cancer Center Nashville Tennessee 37203
Texas Oncology, P.A. Fort Worth Texas 76104
M.D. Anderson Cancer Center Houston Texas 77030
Cancer Care Network of South Texas San Antonio Texas 78217
Virginia Cancer Specialists, PC Fairfax Virginia 22031
Oncology and Hematology Associates of Southwest Virginia, Inc Roanoke Virginia 24014
Seattle Cancer Care Alliance Seattle Washington 98109-1024
Yakima Valley Memorial Hospital / North Star Lodge Yakima Washington 98902
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01539512, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2019 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01539512 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →